By Associate Professor Suzanne Jean Hodgkinson

Conference Presentations

Husin H; Wallace J; Malpas C; Sharmin S; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Prat A; Girard M; Duquette P; Trojano M; Grammond P; Lugaresi A; Onofrj M; Ozakbas S; Butzkueven H; Sola P; Ferraro D; Alroughani R; Grand'Maison F; Terzi M; Lechner-Scott J; Boz C; Hupperts R; Shaygannejad V; Bergamaschi R; Pucci E; Van Pesch V; Hodgkinson S; McCombe P; Granella F; Slee M; Van Wijmeersch B; Karabudak R; Prevost J; Petersen T; Spitaleri D; Barnett M; Solaro C; Iuliano G; Verheul F; Ramo-Tello C; Turkoglu R; Fernandez Bolanos R; Butler E; Macdonell R; Soysal A; Betancur MM; Kalincik T, 2018, 'Determinants of MS re-activation after discontinuing therapies', presented at 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), GERMANY, Berlin, 10 October 2018 - 12 October 2018

Ledingham D; El-Wahsh S; Cappelen-Smith C; Hodgkinson S; McDougall A; Maley M; Cordato D, 2018, 'PARADOXICAL REACTION IN TUBERCULOUS MENINGITIS: A TERTIARY REFERRAL HOSPITAL RETROSPECTIVE EXPERIENCE OF CONCOMITANT IMMUNOSUPPRESSION THERAPY', presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Darwin, 29 May 2018 - 01 June 2018, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.17

Back to profile page